Skip to main content

Latest Market News — Page 127

Page 127 · 30 stories scored 7+ · newest 12:35 PM ET · How scores work

Fri, Oct 2330 stories
7EEni S.p.A.Eni Nears $1.8B Cyprus Gas Contracts as Q3 Earnings DoubleM&A & partnerships · Seeking Alpha▲ Positive7FLGFlagstar Bank, National AssociationFlagstar Hits New 52-Week Low as Q3 Miss Comes With 2028 Target PushEarnings & guidance · Benzinga▼ Negative7LYCALycia TherapeuticsLycia Therapeutics Jumps 32% in Debut After $317.5M Upsized IPOFinancing · Dow Jones Newswires▲ Positive8SLBSLB LimitedSLB Beats on Q3 Revenue as Data-Center Unit Jumps 23% and Middle East RecoversEarnings & guidance · Dow Jones Newswires▲ PositivePro7VRSKVerisk Analytics, Inc.Delaware Supreme Court Upholds Order Forcing Verisk to Close $2.35B AccuLynx DealLegal & risk · Wiseek News▲ Positive7TSLATesla, Inc.Former DOJ Official Warns Tesla-SpaceX Merger Could Draw Antitrust Challenge Over Starlink AccessM&A & partnerships · Benzinga▼ Negative9GMABGenmab A/SPhase 3 Win: Rina-S Cuts Ovarian Cancer Progression Risk 71%, Extends SurvivalProduct & regulatory · BusinessWire▲ PositivePro7BAHBooz Allen Hamilton Holding CorpBooz Allen Falls 4.3% as Civil Unit Drags Q2 Revenue Below ConsensusEarnings & guidance · Seeking Alpha▼ Negative7NRUCNational Rural Utilities Cooperative Finance CorporationS&P Lifts CFC to 'A' on Strong Asset Quality, Stable OutlookGovernance · GlobeNewswire▲ Positive7TGTXTG Therapeutics, Inc.Azer-Cel Shows 89% Stable or Improved Disability Scores in Progressive MS Phase 1Product & regulatory · Reuters▲ Positive7RINGiShares Gold TrustGold Breaks Below $4,000 for First Time Since July, Down 28.7% From January PeakEarnings & guidance · Seeking Alpha▼ Negative7GRCThe Gorman-Rupp CompanyGorman-Rupp Beats on Revenue, Lifts Dividend 5.3% as Shares Climb 5.9%Earnings & guidance · Dow Jones Newswires▲ Positive8VLVCYVolvo Car ABVolvo Swings to Q3 Loss, Shares Plunge 27% as It Cuts 2,500 JobsEarnings & guidance · Seeking Alpha▼ NegativePro7DECKDeckers Outdoor CorpDeckers Guides Q3 to Low-Single-Digit Growth as U.S. DTC Slows; FY27 Sales Outlook CutEarnings & guidance · Benzinga▼ Negative7KYTXKyverna Therapeutics, Inc.Kyverna's miv-cel Shows Two-Year Disability Benefit in Progressive MSProduct & regulatory · GlobeNewswire▲ Positive7AAUKFAnglo American plcMMG Offers Ferronickel Supply Guarantee to Win EU Approval for Anglo Nickel DealM&A & partnerships · Seeking Alpha▲ Positive7RNGRingCentral, Inc.Analysts Hike RingCentral Targets After Third Straight Quarter of Subscription AccelerationEarnings & guidance · Seeking Alpha▲ Positive7ZNTLZentalis Pharmaceuticals, Inc.Azenosertib OS Separation Confirmed: 15.9 vs 7.5 Months in Cyclin E1-Positive Ovarian CancerProduct & regulatory · GlobeNewswire▲ Positive7IOVAIovance Biotherapeutics, Inc.Lifileucel Plus Keytruda Hits 62.5% Response Rate in Frontline MelanomaProduct & regulatory · GlobeNewswire▲ Positive7JAZZJazz Pharmaceuticals plcZiihera Regimens Show 27-Month Median Survival at Three Years in First-Line HER2+ GEAProduct & regulatory · PR Newswire▲ Positive7LZMLifezone Metals LtdLifezone Confirms Advanced Talks on Strategic Equity Investment in Kabanga NickelM&A & partnerships · BusinessWire▲ Positive7BEBloom Energy CorpBloom Energy Falls 9.2% as Cash Burn Overshadows Q3 Beat and Raised GuidanceEarnings & guidance · Seeking Alpha▼ Negative8AIOKAI OKTO Corp.Special Dividend of $3.50 Per Share Declared, Roughly 86% of Stock PriceFinancing · GlobeNewswire▲ PositivePro7MGNXMacroGenics Inc.MGC026 Shows 27% Response Rate in Heavily Pretreated Head and Neck Cancer; Front-Line Pembro Combo Study PlannedProduct & regulatory · GlobeNewswire▲ Positive9BOLTBolt Biotherapeutics, Inc.Bolt Buys Prana Therapies, Raises $120M to Fund PRA-216M&A & partnerships · Dow Jones Newswires▲ PositivePro7VIVKVivakor, Inc.Vivakor's $40M Direct Midstream Deal Advances Toward Purchase AgreementM&A & partnerships · Dow Jones Newswires▲ Positive9ELTXElicio Therapeutics, Inc.Elicio's Lead Cancer Vaccine Misses Primary Endpoint in Phase 2 TrialProduct & regulatory · Wiseek News▼ NegativePro7TEMTempus AI, Inc.BMS Expands Tempus Data Deal Through 2031, Becomes Top Oncology Data LicensorM&A & partnerships · BusinessWire▲ Positive7VRSNVeriSign, Inc.VeriSign Falls 5% on EPS Miss as Analysts Back Raised Domain Growth OutlookEarnings & guidance · Seeking Alpha▼ Negative9LKQLKQ CorporationLKQ Ousts CEO Jude, Warns Q3 EPS Will Miss Badly as Europe CrumblesExecutive changes · Dow Jones Newswires▼ NegativePro
How Wiseek picks and scores these

How Wiseek curates this list

Every entry started life as licensed wire-service reporting (Reuters, Dow Jones Newswires, and similar publishers) covering ticker-attributable events. Wiseek's editorial pipeline ingests these in real time, runs each headline through our domain-tuned importance scorer, and surfaces only items rated 7 or higher on a 1–10 market-impact scale. Items below 7 are filtered out at the database query so the public feed stays signal-dense.

What "AI-ranked analysis" means

For each item we publish a plain-English summary, a sentiment label (positive / negative / neutral), and a structured list of key events extracted from the underlying source. Score, summary, and sentiment come from Wiseek's in-house models — not generic chatbot output. See our methodology for the full pipeline and our editorial policy for source-attribution standards.

What's not on this page

Generic market commentary, opinion columns, low-impact press releases, and items below the 7-point importance threshold. Wiseek aggregates and scores wire-service headlines; the underlying publishers retain their original reporting and are credited per article.

Track by company

Follow SEC filings and market news for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.